 Xianzhong Meng
Concepts (401)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve | 39 | 2023 | 477 | 11.490 |
Why?
| | Aortic Valve Stenosis | 29 | 2023 | 322 | 8.430 |
Why?
| | Calcinosis | 22 | 2022 | 294 | 6.880 |
Why?
| | Toll-Like Receptor 4 | 32 | 2021 | 366 | 6.770 |
Why?
| | Osteogenesis | 17 | 2022 | 220 | 5.380 |
Why?
| | Toll-Like Receptor 2 | 12 | 2022 | 141 | 3.940 |
Why?
| | NF-kappa B | 25 | 2022 | 688 | 3.450 |
Why?
| | Intercellular Adhesion Molecule-1 | 17 | 2022 | 174 | 3.060 |
Why?
| | Bone Morphogenetic Protein 2 | 14 | 2018 | 95 | 2.780 |
Why?
| | Cells, Cultured | 36 | 2023 | 4191 | 2.240 |
Why?
| | Myocardium | 12 | 2017 | 1001 | 2.190 |
Why?
| | Monocytes | 3 | 2022 | 510 | 2.060 |
Why?
| | Glucuronidase | 3 | 2020 | 51 | 2.030 |
Why?
| | Heart Valve Diseases | 5 | 2020 | 182 | 1.990 |
Why?
| | Endotoxemia | 7 | 2017 | 92 | 1.890 |
Why?
| | Lipoproteins, LDL | 5 | 2017 | 149 | 1.720 |
Why?
| | Biglycan | 4 | 2017 | 11 | 1.710 |
Why?
| | Myocardial Reperfusion Injury | 5 | 2015 | 127 | 1.690 |
Why?
| | Up-Regulation | 14 | 2020 | 900 | 1.650 |
Why?
| | Reperfusion Injury | 8 | 2022 | 282 | 1.440 |
Why?
| | Receptor, Notch1 | 3 | 2014 | 67 | 1.430 |
Why?
| | Interleukins | 4 | 2022 | 244 | 1.420 |
Why?
| | Signal Transduction | 29 | 2023 | 4824 | 1.420 |
Why?
| | Neurotrophin 3 | 2 | 2020 | 18 | 1.420 |
Why?
| | Matrilin Proteins | 4 | 2022 | 17 | 1.400 |
Why?
| | Proto-Oncogene Proteins c-akt | 5 | 2020 | 441 | 1.380 |
Why?
| | Myofibroblasts | 4 | 2018 | 130 | 1.320 |
Why?
| | Inflammation Mediators | 4 | 2022 | 528 | 1.250 |
Why?
| | Heart | 8 | 2017 | 655 | 1.230 |
Why?
| | Interleukin-1 | 5 | 2022 | 1028 | 1.230 |
Why?
| | Lipopolysaccharides | 17 | 2020 | 903 | 1.230 |
Why?
| | Tumor Necrosis Factor-alpha | 9 | 2013 | 1194 | 1.220 |
Why?
| | Transforming Growth Factor beta1 | 3 | 2017 | 175 | 1.200 |
Why?
| | Esophageal Neoplasms | 10 | 2022 | 237 | 1.120 |
Why?
| | Matrix Metalloproteinases | 2 | 2017 | 92 | 1.110 |
Why?
| | Down-Regulation | 6 | 2020 | 648 | 1.090 |
Why?
| | Coronary Vessels | 2 | 2021 | 260 | 1.090 |
Why?
| | Vascular Calcification | 2 | 2017 | 125 | 1.080 |
Why?
| | Collagen | 4 | 2022 | 426 | 1.070 |
Why?
| | Chemokine CCL2 | 5 | 2017 | 128 | 1.060 |
Why?
| | Spinal Cord Ischemia | 8 | 2018 | 79 | 1.010 |
Why?
| | MicroRNAs | 3 | 2019 | 631 | 0.980 |
Why?
| | Inflammation | 10 | 2021 | 2538 | 0.970 |
Why?
| | Endothelial Cells | 3 | 2021 | 660 | 0.960 |
Why?
| | Extracellular Matrix Proteins | 3 | 2021 | 125 | 0.920 |
Why?
| | Chemokines | 4 | 2015 | 230 | 0.880 |
Why?
| | Heart Diseases | 2 | 2022 | 367 | 0.860 |
Why?
| | Group II Phospholipases A2 | 7 | 2020 | 26 | 0.850 |
Why?
| | Recombinant Proteins | 9 | 2022 | 1322 | 0.830 |
Why?
| | Receptor, trkA | 2 | 2020 | 24 | 0.830 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 4 | 2020 | 180 | 0.830 |
Why?
| | HSP70 Heat-Shock Proteins | 4 | 2017 | 76 | 0.820 |
Why?
| | Adenocarcinoma | 10 | 2022 | 818 | 0.820 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 4 | 2021 | 159 | 0.810 |
Why?
| | Mice, Inbred C57BL | 22 | 2022 | 5136 | 0.780 |
Why?
| | Disease Susceptibility | 1 | 2022 | 337 | 0.750 |
Why?
| | Osteoblasts | 2 | 2017 | 110 | 0.750 |
Why?
| | Phospholipases A2, Secretory | 6 | 2019 | 27 | 0.740 |
Why?
| | Alkaline Phosphatase | 7 | 2019 | 155 | 0.730 |
Why?
| | HSC70 Heat-Shock Proteins | 2 | 2009 | 7 | 0.720 |
Why?
| | Toll-Like Receptor 3 | 2 | 2017 | 32 | 0.710 |
Why?
| | Aging | 3 | 2022 | 1690 | 0.700 |
Why?
| | Gastroesophageal Reflux | 6 | 2022 | 246 | 0.700 |
Why?
| | Myeloid Differentiation Factor 88 | 3 | 2020 | 103 | 0.700 |
Why?
| | Male | 50 | 2022 | 60403 | 0.670 |
Why?
| | Myocardial Contraction | 3 | 2008 | 349 | 0.670 |
Why?
| | Barrett Esophagus | 5 | 2022 | 148 | 0.660 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 5 | 2022 | 397 | 0.660 |
Why?
| | Animals | 46 | 2022 | 34350 | 0.660 |
Why?
| | ADAMTS5 Protein | 1 | 2017 | 7 | 0.650 |
Why?
| | Anti-Inflammatory Agents | 2 | 2022 | 472 | 0.650 |
Why?
| | Neutrophil Infiltration | 3 | 2009 | 99 | 0.640 |
Why?
| | SOX9 Transcription Factor | 1 | 2017 | 18 | 0.640 |
Why?
| | Cell Transdifferentiation | 1 | 2017 | 34 | 0.630 |
Why?
| | Heart Defects, Congenital | 3 | 2020 | 721 | 0.630 |
Why?
| | Core Binding Factor Alpha 1 Subunit | 7 | 2023 | 51 | 0.630 |
Why?
| | Cyclin D1 | 1 | 2017 | 66 | 0.630 |
Why?
| | Middle Aged | 25 | 2022 | 28659 | 0.630 |
Why?
| | HSP27 Heat-Shock Proteins | 2 | 2014 | 14 | 0.630 |
Why?
| | Humans | 67 | 2023 | 117633 | 0.630 |
Why?
| | Lysophosphatidylcholines | 1 | 2017 | 35 | 0.630 |
Why?
| | Mice | 35 | 2022 | 15537 | 0.620 |
Why?
| | RNA, Double-Stranded | 1 | 2017 | 51 | 0.620 |
Why?
| | Epigenesis, Genetic | 2 | 2017 | 503 | 0.590 |
Why?
| | Cell Proliferation | 11 | 2020 | 2369 | 0.590 |
Why?
| | Phosphates | 1 | 2017 | 176 | 0.580 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 4 | 2022 | 43 | 0.570 |
Why?
| | RNA Interference | 6 | 2017 | 489 | 0.560 |
Why?
| | Immunity, Innate | 3 | 2019 | 756 | 0.550 |
Why?
| | Extracellular Space | 3 | 2010 | 140 | 0.550 |
Why?
| | Aged | 16 | 2019 | 20249 | 0.540 |
Why?
| | Myocarditis | 3 | 2011 | 89 | 0.500 |
Why?
| | Immune Tolerance | 2 | 2019 | 342 | 0.490 |
Why?
| | Enzyme Inhibitors | 6 | 2020 | 874 | 0.490 |
Why?
| | Ventricular Function, Left | 1 | 2017 | 503 | 0.490 |
Why?
| | Receptors, Erythropoietin | 3 | 2018 | 24 | 0.480 |
Why?
| | Simvastatin | 5 | 2022 | 70 | 0.480 |
Why?
| | Myocardial Ischemia | 3 | 2011 | 268 | 0.460 |
Why?
| | Mice, Knockout | 9 | 2017 | 2805 | 0.430 |
Why?
| | Interleukin-6 | 5 | 2022 | 708 | 0.430 |
Why?
| | Erythropoietin | 3 | 2018 | 80 | 0.430 |
Why?
| | Esophagus | 4 | 2020 | 239 | 0.420 |
Why?
| | Spinal Cord | 5 | 2018 | 400 | 0.410 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2022 | 134 | 0.400 |
Why?
| | Mice, Inbred C3H | 6 | 2021 | 263 | 0.390 |
Why?
| | Cytokines | 7 | 2017 | 1951 | 0.390 |
Why?
| | Transfection | 5 | 2017 | 910 | 0.380 |
Why?
| | Interleukin-1beta | 2 | 2013 | 414 | 0.380 |
Why?
| | Gene Knockdown Techniques | 3 | 2017 | 327 | 0.380 |
Why?
| | Lipopeptides | 2 | 2020 | 18 | 0.370 |
Why?
| | Lung Neoplasms | 7 | 2019 | 2171 | 0.370 |
Why?
| | Case-Control Studies | 5 | 2017 | 3269 | 0.360 |
Why?
| | Endotoxins | 1 | 2010 | 247 | 0.360 |
Why?
| | Shock, Hemorrhagic | 3 | 2012 | 230 | 0.360 |
Why?
| | Actins | 3 | 2017 | 365 | 0.350 |
Why?
| | Actin Cytoskeleton | 1 | 2009 | 91 | 0.350 |
Why?
| | Calcium-Binding Proteins | 3 | 2015 | 217 | 0.340 |
Why?
| | Female | 16 | 2022 | 63247 | 0.340 |
Why?
| | Receptors, Cell Surface | 3 | 2004 | 374 | 0.330 |
Why?
| | Esophagitis, Peptic | 2 | 2022 | 15 | 0.320 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2008 | 398 | 0.320 |
Why?
| | Disease Models, Animal | 13 | 2022 | 3799 | 0.310 |
Why?
| | Phenotype | 7 | 2017 | 2875 | 0.300 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 5 | 2018 | 293 | 0.300 |
Why?
| | RNA, Small Interfering | 3 | 2014 | 587 | 0.280 |
Why?
| | Immunoblotting | 3 | 2017 | 328 | 0.280 |
Why?
| | Dexmedetomidine | 3 | 2014 | 47 | 0.280 |
Why?
| | Interleukin-18 | 2 | 2006 | 229 | 0.270 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2004 | 83 | 0.260 |
Why?
| | Ischemia | 2 | 2022 | 326 | 0.260 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 4 | 2014 | 995 | 0.260 |
Why?
| | Spinal Cord Injuries | 2 | 2018 | 154 | 0.260 |
Why?
| | Intercellular Signaling Peptides and Proteins | 3 | 2013 | 347 | 0.260 |
Why?
| | Neuroprotective Agents | 2 | 2018 | 123 | 0.250 |
Why?
| | Adrenergic alpha-2 Receptor Agonists | 2 | 2014 | 28 | 0.250 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 6 | 2017 | 858 | 0.250 |
Why?
| | Biomarkers | 4 | 2022 | 3574 | 0.250 |
Why?
| | Gene Expression Regulation | 6 | 2017 | 2527 | 0.240 |
Why?
| | Jagged-1 Protein | 2 | 2013 | 25 | 0.240 |
Why?
| | Serrate-Jagged Proteins | 2 | 2013 | 29 | 0.240 |
Why?
| | Fluorescent Antibody Technique | 7 | 2010 | 419 | 0.240 |
Why?
| | Receptors, Interleukin-9 | 1 | 2022 | 5 | 0.240 |
Why?
| | MAP Kinase Signaling System | 2 | 2015 | 297 | 0.230 |
Why?
| | Phosphorylation | 5 | 2013 | 1678 | 0.230 |
Why?
| | Smad1 Protein | 2 | 2014 | 19 | 0.230 |
Why?
| | Apoptosis | 5 | 2018 | 2573 | 0.230 |
Why?
| | Mice, Transgenic | 3 | 2017 | 2100 | 0.230 |
Why?
| | Infarction | 1 | 2022 | 14 | 0.230 |
Why?
| | CD18 Antigens | 1 | 2022 | 40 | 0.230 |
Why?
| | Culture Media, Conditioned | 1 | 2022 | 109 | 0.220 |
Why?
| | Neoplasm Proteins | 2 | 2019 | 411 | 0.220 |
Why?
| | Diazoxide | 2 | 2018 | 32 | 0.220 |
Why?
| | Tumor Burden | 2 | 2020 | 283 | 0.220 |
Why?
| | Heat-Shock Proteins | 2 | 2014 | 132 | 0.210 |
Why?
| | Lab-On-A-Chip Devices | 1 | 2021 | 39 | 0.210 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2022 | 157 | 0.210 |
Why?
| | Caspases | 1 | 2022 | 276 | 0.210 |
Why?
| | Pentanoic Acids | 1 | 2020 | 3 | 0.210 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 7 | 2015 | 1052 | 0.210 |
Why?
| | Inflammasomes | 1 | 2022 | 122 | 0.210 |
Why?
| | Microglia | 2 | 2013 | 261 | 0.200 |
Why?
| | Adaptor Proteins, Vesicular Transport | 2 | 2019 | 49 | 0.200 |
Why?
| | Mice, Inbred NOD | 1 | 2022 | 579 | 0.200 |
Why?
| | In Vitro Techniques | 3 | 2009 | 1143 | 0.200 |
Why?
| | Indole Alkaloids | 1 | 2020 | 12 | 0.200 |
Why?
| | Dinoprostone | 2 | 2019 | 203 | 0.200 |
Why?
| | Time Factors | 7 | 2014 | 6906 | 0.200 |
Why?
| | Gene Expression | 4 | 2009 | 1520 | 0.190 |
Why?
| | eIF-2 Kinase | 1 | 2020 | 31 | 0.190 |
Why?
| | Primary Cell Culture | 2 | 2018 | 166 | 0.190 |
Why?
| | Carbazoles | 1 | 2020 | 87 | 0.190 |
Why?
| | STAT3 Transcription Factor | 3 | 2019 | 196 | 0.180 |
Why?
| | Wnt Signaling Pathway | 1 | 2020 | 136 | 0.180 |
Why?
| | Matrix Metalloproteinase 12 | 1 | 2018 | 8 | 0.180 |
Why?
| | Blotting, Western | 7 | 2020 | 1246 | 0.180 |
Why?
| | Cell Line, Tumor | 9 | 2020 | 2898 | 0.180 |
Why?
| | Cell Adhesion Molecules | 2 | 2021 | 178 | 0.180 |
Why?
| | RNA, Neoplasm | 1 | 2018 | 78 | 0.170 |
Why?
| | Cell Movement | 2 | 2014 | 925 | 0.170 |
Why?
| | Heme Oxygenase-1 | 2 | 2009 | 49 | 0.170 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2020 | 1193 | 0.170 |
Why?
| | Sp7 Transcription Factor | 1 | 2017 | 8 | 0.160 |
Why?
| | Antagomirs | 1 | 2017 | 14 | 0.160 |
Why?
| | Sclerosis | 1 | 2017 | 14 | 0.160 |
Why?
| | Toll-Like Receptors | 2 | 2017 | 177 | 0.160 |
Why?
| | Cell Line | 3 | 2020 | 2832 | 0.160 |
Why?
| | Collagen Type III | 1 | 2017 | 20 | 0.160 |
Why?
| | Mice, Mutant Strains | 2 | 2008 | 293 | 0.160 |
Why?
| | Poly I-C | 1 | 2017 | 55 | 0.160 |
Why?
| | Neutrophils | 6 | 2012 | 1263 | 0.160 |
Why?
| | Mice, Inbred Strains | 3 | 2008 | 440 | 0.160 |
Why?
| | NFATC Transcription Factors | 1 | 2017 | 85 | 0.160 |
Why?
| | Calcium | 2 | 2022 | 1203 | 0.160 |
Why?
| | Cattle | 2 | 2010 | 950 | 0.150 |
Why?
| | Collagen Type I | 1 | 2017 | 134 | 0.150 |
Why?
| | Membrane Proteins | 2 | 2013 | 1081 | 0.150 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2017 | 164 | 0.140 |
Why?
| | Adult | 10 | 2018 | 32118 | 0.140 |
Why?
| | Biomarkers, Tumor | 2 | 2020 | 1049 | 0.140 |
Why?
| | Molecular Chaperones | 2 | 2014 | 179 | 0.140 |
Why?
| | Protein Kinase C | 1 | 2017 | 314 | 0.140 |
Why?
| | Macrophages | 4 | 2011 | 1332 | 0.140 |
Why?
| | Mucous Membrane | 3 | 2010 | 113 | 0.140 |
Why?
| | RNA, Messenger | 8 | 2012 | 2757 | 0.140 |
Why?
| | Smad3 Protein | 1 | 2014 | 48 | 0.140 |
Why?
| | Cardiovascular Surgical Procedures | 1 | 2014 | 39 | 0.130 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2020 | 2106 | 0.130 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2017 | 155 | 0.130 |
Why?
| | Enzyme Activation | 3 | 2013 | 883 | 0.130 |
Why?
| | Paraplegia | 2 | 2011 | 59 | 0.130 |
Why?
| | Models, Biological | 1 | 2022 | 1763 | 0.130 |
Why?
| | Solubility | 1 | 2014 | 245 | 0.120 |
Why?
| | Microfilament Proteins | 1 | 2014 | 128 | 0.120 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type III | 1 | 2013 | 6 | 0.120 |
Why?
| | Duodenogastric Reflux | 2 | 2010 | 4 | 0.120 |
Why?
| | Calcium Phosphates | 1 | 2013 | 28 | 0.120 |
Why?
| | Osteopontin | 2 | 2012 | 38 | 0.120 |
Why?
| | Drug Evaluation, Preclinical | 3 | 2020 | 187 | 0.120 |
Why?
| | Mice, Inbred BALB C | 4 | 2010 | 1254 | 0.120 |
Why?
| | Protein Binding | 2 | 2010 | 2018 | 0.120 |
Why?
| | Astrocytes | 1 | 2014 | 164 | 0.120 |
Why?
| | Dipeptides | 1 | 2012 | 51 | 0.120 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 2012 | 49 | 0.110 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2012 | 75 | 0.110 |
Why?
| | ras Proteins | 1 | 2012 | 147 | 0.110 |
Why?
| | Diiodothyronines | 1 | 2011 | 4 | 0.110 |
Why?
| | Deoxycholic Acid | 2 | 2021 | 21 | 0.110 |
Why?
| | Propionates | 1 | 2011 | 34 | 0.110 |
Why?
| | Radiation Injuries | 1 | 2012 | 137 | 0.110 |
Why?
| | Aorta, Abdominal | 1 | 2011 | 35 | 0.110 |
Why?
| | Antibodies, Neutralizing | 2 | 2012 | 210 | 0.100 |
Why?
| | Lung | 5 | 2012 | 3645 | 0.100 |
Why?
| | Genetic Therapy | 1 | 2012 | 268 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2017 | 862 | 0.100 |
Why?
| | Antineoplastic Agents | 2 | 2012 | 2016 | 0.100 |
Why?
| | Ischemic Preconditioning, Myocardial | 1 | 2010 | 33 | 0.100 |
Why?
| | Cardiomyopathies | 1 | 2014 | 309 | 0.100 |
Why?
| | Motor Activity | 2 | 2013 | 723 | 0.100 |
Why?
| | Neoplastic Stem Cells | 1 | 2014 | 335 | 0.100 |
Why?
| | Heart Function Tests | 1 | 2010 | 75 | 0.100 |
Why?
| | A549 Cells | 2 | 2020 | 53 | 0.100 |
Why?
| | Interleukin-8 | 2 | 2008 | 254 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2017 | 928 | 0.100 |
Why?
| | Antibodies | 2 | 2002 | 405 | 0.100 |
Why?
| | Actinin | 1 | 2009 | 14 | 0.090 |
Why?
| | Cell Survival | 4 | 2014 | 1104 | 0.090 |
Why?
| | Acute Lung Injury | 1 | 2012 | 310 | 0.090 |
Why?
| | Polymerization | 1 | 2009 | 128 | 0.090 |
Why?
| | Phospholipases A2 | 1 | 2008 | 85 | 0.090 |
Why?
| | Ventricular Pressure | 1 | 2008 | 35 | 0.090 |
Why?
| | Mutation | 2 | 2012 | 3409 | 0.080 |
Why?
| | Proto-Oncogene Proteins | 1 | 2012 | 682 | 0.080 |
Why?
| | Peptidoglycan | 1 | 2007 | 24 | 0.080 |
Why?
| | beta Catenin | 2 | 2021 | 223 | 0.080 |
Why?
| | Random Allocation | 3 | 2020 | 385 | 0.080 |
Why?
| | Myocardial Depressant Factor | 1 | 2007 | 3 | 0.080 |
Why?
| | Perfusion | 1 | 2008 | 167 | 0.080 |
Why?
| | Oxyhemoglobins | 1 | 2007 | 19 | 0.080 |
Why?
| | Blood Substitutes | 1 | 2007 | 20 | 0.080 |
Why?
| | Pulmonary Valve | 1 | 2009 | 93 | 0.080 |
Why?
| | Lower Extremity | 1 | 2011 | 306 | 0.080 |
Why?
| | Kupffer Cells | 1 | 2007 | 52 | 0.080 |
Why?
| | Hemoglobins | 1 | 2009 | 282 | 0.080 |
Why?
| | Hyperplasia | 2 | 2010 | 162 | 0.080 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2007 | 138 | 0.080 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2012 | 597 | 0.080 |
Why?
| | Analysis of Variance | 4 | 2012 | 1451 | 0.070 |
Why?
| | Caspase 1 | 1 | 2006 | 149 | 0.070 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2008 | 323 | 0.070 |
Why?
| | Protein Structure, Tertiary | 1 | 2008 | 840 | 0.070 |
Why?
| | Mice, Nude | 2 | 2020 | 685 | 0.070 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2004 | 37 | 0.070 |
Why?
| | Cell Culture Techniques | 2 | 2019 | 352 | 0.070 |
Why?
| | Glutamine | 1 | 2005 | 81 | 0.070 |
Why?
| | Binding Sites | 1 | 2008 | 1261 | 0.070 |
Why?
| | Transforming Growth Factor beta | 1 | 2007 | 469 | 0.070 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2020 | 770 | 0.070 |
Why?
| | Disease Progression | 2 | 2020 | 2541 | 0.060 |
Why?
| | Microscopy, Fluorescence | 2 | 2018 | 420 | 0.060 |
Why?
| | Mycobacterium tuberculosis | 1 | 2006 | 295 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2011 | 1152 | 0.060 |
Why?
| | DNA | 1 | 2010 | 1363 | 0.060 |
Why?
| | Immunohistochemistry | 4 | 2009 | 1756 | 0.060 |
Why?
| | Cell Adhesion | 2 | 2020 | 453 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2006 | 745 | 0.060 |
Why?
| | Vinblastine | 1 | 2002 | 71 | 0.060 |
Why?
| | Leukocyte Elastase | 1 | 2002 | 85 | 0.060 |
Why?
| | Tunica Intima | 1 | 2002 | 80 | 0.060 |
Why?
| | Carotid Artery Injuries | 1 | 2002 | 43 | 0.060 |
Why?
| | Annexin A5 | 1 | 2022 | 25 | 0.060 |
Why?
| | Chemotactic Factors | 1 | 2002 | 50 | 0.060 |
Why?
| | Adenosine Triphosphatases | 1 | 2023 | 168 | 0.060 |
Why?
| | Chemokines, CXC | 1 | 2002 | 63 | 0.060 |
Why?
| | Growth Substances | 1 | 2002 | 132 | 0.050 |
Why?
| | Neoplasm Invasiveness | 2 | 2014 | 456 | 0.050 |
Why?
| | Cell Count | 1 | 2002 | 323 | 0.050 |
Why?
| | Peroxidase | 3 | 2012 | 185 | 0.050 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2019 | 524 | 0.050 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2002 | 193 | 0.050 |
Why?
| | Caspase 3 | 1 | 2022 | 249 | 0.050 |
Why?
| | Flow Cytometry | 3 | 2011 | 1132 | 0.050 |
Why?
| | Receptors, Interleukin-1 | 1 | 2002 | 247 | 0.050 |
Why?
| | Tissue Banks | 1 | 2020 | 19 | 0.050 |
Why?
| | Drosophila Proteins | 1 | 2002 | 179 | 0.050 |
Why?
| | Esophageal Mucosa | 1 | 2020 | 18 | 0.050 |
Why?
| | Warfarin | 1 | 2021 | 139 | 0.050 |
Why?
| | Postoperative Complications | 1 | 2011 | 2113 | 0.050 |
Why?
| | Membrane Glycoproteins | 1 | 2002 | 453 | 0.050 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-6 | 1 | 2018 | 7 | 0.050 |
Why?
| | Tumor Cells, Cultured | 2 | 2011 | 920 | 0.040 |
Why?
| | Fibrosis | 1 | 2020 | 458 | 0.040 |
Why?
| | Protein Multimerization | 1 | 2019 | 165 | 0.040 |
Why?
| | Crystallography, X-Ray | 1 | 2019 | 437 | 0.040 |
Why?
| | Receptor, ErbB-2 | 1 | 2020 | 318 | 0.040 |
Why?
| | ErbB Receptors | 1 | 2020 | 568 | 0.040 |
Why?
| | Sepsis | 1 | 2002 | 491 | 0.040 |
Why?
| | Brain | 1 | 2009 | 2699 | 0.040 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2012 | 633 | 0.030 |
Why?
| | Rats, Sprague-Dawley | 3 | 2009 | 2854 | 0.030 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 1 | 2014 | 12 | 0.030 |
Why?
| | Tensins | 1 | 2014 | 3 | 0.030 |
Why?
| | Aminosalicylic Acids | 1 | 2014 | 7 | 0.030 |
Why?
| | Cardiomyopathy, Dilated | 1 | 2018 | 356 | 0.030 |
Why?
| | Benzenesulfonates | 1 | 2014 | 22 | 0.030 |
Why?
| | Epidermal Growth Factor | 1 | 2014 | 165 | 0.030 |
Why?
| | Foscarnet | 1 | 2013 | 20 | 0.030 |
Why?
| | Nerve Degeneration | 1 | 2013 | 45 | 0.030 |
Why?
| | Minocycline | 1 | 2013 | 36 | 0.030 |
Why?
| | Sensitivity and Specificity | 2 | 2008 | 1897 | 0.030 |
Why?
| | Cell Growth Processes | 1 | 2012 | 52 | 0.030 |
Why?
| | Leukotriene C4 | 1 | 2012 | 16 | 0.030 |
Why?
| | Monokines | 2 | 2002 | 25 | 0.030 |
Why?
| | Leukotriene B4 | 1 | 2012 | 60 | 0.030 |
Why?
| | Ki-67 Antigen | 1 | 2012 | 108 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 2012 | 39 | 0.030 |
Why?
| | Chemokine CXCL2 | 2 | 2002 | 44 | 0.030 |
Why?
| | Heart Transplantation | 1 | 2018 | 745 | 0.030 |
Why?
| | Eicosanoids | 1 | 2012 | 64 | 0.030 |
Why?
| | Pravastatin | 1 | 2011 | 28 | 0.030 |
Why?
| | Rats | 3 | 2009 | 6016 | 0.030 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 170 | 0.030 |
Why?
| | Heptanoic Acids | 1 | 2011 | 67 | 0.030 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 234 | 0.030 |
Why?
| | Radiotherapy | 1 | 2012 | 191 | 0.030 |
Why?
| | Constriction | 1 | 2011 | 49 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 309 | 0.030 |
Why?
| | Subclavian Artery | 1 | 2011 | 27 | 0.030 |
Why?
| | Culture Media | 1 | 2011 | 170 | 0.030 |
Why?
| | Pyrroles | 1 | 2011 | 200 | 0.020 |
Why?
| | Hindlimb | 1 | 2011 | 138 | 0.020 |
Why?
| | Indoles | 1 | 2012 | 332 | 0.020 |
Why?
| | Glucose | 1 | 2014 | 926 | 0.020 |
Why?
| | Molecular Targeted Therapy | 1 | 2012 | 376 | 0.020 |
Why?
| | Neoplasm Staging | 1 | 2012 | 1215 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 593 | 0.020 |
Why?
| | Hypoxia | 1 | 2014 | 923 | 0.020 |
Why?
| | Aorta, Thoracic | 1 | 2011 | 243 | 0.020 |
Why?
| | Organ Specificity | 1 | 2009 | 281 | 0.020 |
Why?
| | Prospective Studies | 1 | 2020 | 6422 | 0.020 |
Why?
| | Acute Disease | 1 | 2011 | 983 | 0.020 |
Why?
| | Infusions, Intravenous | 1 | 2009 | 393 | 0.020 |
Why?
| | Tissue and Organ Harvesting | 1 | 2008 | 68 | 0.020 |
Why?
| | Biopsy, Needle | 1 | 2008 | 193 | 0.020 |
Why?
| | HSP72 Heat-Shock Proteins | 1 | 2007 | 30 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2008 | 339 | 0.020 |
Why?
| | Cell Division | 1 | 2009 | 789 | 0.020 |
Why?
| | Probability | 1 | 2008 | 325 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2021 | 9353 | 0.020 |
Why?
| | Precancerous Conditions | 1 | 2008 | 158 | 0.020 |
Why?
| | Age Factors | 1 | 2014 | 3223 | 0.020 |
Why?
| | Prevalence | 1 | 2013 | 2438 | 0.020 |
Why?
| | Quercetin | 1 | 2005 | 14 | 0.020 |
Why?
| | Protein Isoforms | 1 | 2006 | 344 | 0.020 |
Why?
| | Lymphocytes | 1 | 2006 | 370 | 0.020 |
Why?
| | Epithelial Cells | 1 | 2010 | 988 | 0.020 |
Why?
| | Group IB Phospholipases A2 | 1 | 2002 | 2 | 0.010 |
Why?
| | Receptors, Phospholipase A2 | 1 | 2002 | 3 | 0.010 |
Why?
| | Dendritic Cells | 1 | 2006 | 474 | 0.010 |
Why?
| | Binding, Competitive | 1 | 2002 | 208 | 0.010 |
Why?
| | Chelating Agents | 1 | 2002 | 83 | 0.010 |
Why?
| | Oxygen | 1 | 2007 | 864 | 0.010 |
Why?
| | Phospholipases A | 1 | 2002 | 121 | 0.010 |
Why?
| | Chemokine CXCL1 | 1 | 2002 | 67 | 0.010 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 170 | 0.010 |
Why?
| | Cell Separation | 1 | 2002 | 309 | 0.010 |
Why?
| | Infant | 1 | 2014 | 8255 | 0.010 |
Why?
| | Muscle, Skeletal | 1 | 2011 | 1539 | 0.010 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2002 | 321 | 0.010 |
Why?
| | Carotid Arteries | 1 | 2002 | 186 | 0.010 |
Why?
| | Fluorescent Dyes | 1 | 2002 | 308 | 0.010 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 268 | 0.010 |
Why?
| | Trachea | 1 | 2002 | 221 | 0.010 |
Why?
| | Child, Preschool | 1 | 2014 | 9714 | 0.010 |
Why?
| | Salmonella typhimurium | 1 | 2002 | 178 | 0.010 |
Why?
| | Risk Factors | 1 | 2013 | 9124 | 0.010 |
Why?
| | Pulmonary Alveoli | 1 | 2002 | 395 | 0.010 |
Why?
| | Cell Membrane | 1 | 2002 | 728 | 0.010 |
Why?
| | Escherichia coli | 1 | 2002 | 789 | 0.010 |
Why?
| | Young Adult | 1 | 2013 | 11077 | 0.010 |
Why?
| | Adolescent | 1 | 2014 | 18902 | 0.010 |
Why?
| | Liver | 1 | 2002 | 1856 | 0.010 |
Why?
|
|
Meng's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|